Cargando…

Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis

OBJECTIVE: Diabetes and hyperglycemia are important risk factors for poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19). We hypothesized that achieving glycemic control soon after admission, in both intensive care unit (ICU) and non-ICU settings, could affect outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klonoff, David C., Messler, Jordan C., Umpierrez, Guillermo E., Peng, Limin, Booth, Robby, Crowe, Jennifer, Garrett, Valerie, McFarland, Raymie, Pasquel, Francisco J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818335/ https://www.ncbi.nlm.nih.gov/pubmed/33323475 http://dx.doi.org/10.2337/dc20-1857

Ejemplares similares

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery
por: Cardona, Saumeth, et al.
Publicado: (2019)

Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
por: Shah, Hetal S., et al.
Publicado: (2018)

Association between hemoglobin A1c variability and hypoglycemia-related hospitalizations in veterans with diabetes mellitus
por: Zhao, Molly J Y, et al.
Publicado: (2021)

Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients
por: Reges, Orna, et al.
Publicado: (2023)

Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study
por: Kaze, Arnaud D, et al.
Publicado: (2020)

Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study
por: Alkandari, Abdullah, et al.
Publicado: (2023)

Exercise capacity is associated with hospital readmission among patients with diabetes
por: Zisman-Ilani, Yaara, et al.
Publicado: (2020)

Egg ingestion in adults with type 2 diabetes: effects on glycemic control, anthropometry, and diet quality—a randomized, controlled, crossover trial
por: Njike, Valentine Y, et al.
Publicado: (2016)

Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes
por: Wong, Rachel, et al.
Publicado: (2022)

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
por: Perreault, Leigh, et al.
Publicado: (2022)

Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort
por: Gulanski, Barbara I, et al.
Publicado: (2023)

Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized Patients
por: Bruno, Alberto, et al.
Publicado: (2008)

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
por: Berg, David D., et al.
Publicado: (2021)

Effect of High-Intensity Interval Training on Glycemic Control in Adults With Type 1 Diabetes and Overweight or Obesity: A Randomized Controlled Trial With Partial Crossover
por: Lee, Angela S., et al.
Publicado: (2020)

Intensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes
por: Kishimoto, Ichiro, et al.
Publicado: (2015)

How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing
por: Ford, Katherine J, et al.
Publicado: (2023)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study
por: Yang, Fude, et al.
Publicado: (2020)

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19
por: Pasquel, Francisco J., et al.
Publicado: (2021)

PSUN191 Hospital Outcomes of Intensive and Standard Inpatient Glycemic Targets: A Propensity Scored-Matched Post Hoc Analysis of Insulin-Treated Patients with Type 2 Diabetes
por: Fafyman, Maya, et al.
Publicado: (2022)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes
por: Tang, Xin, et al.
Publicado: (2022)

Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes
por: Kanamori, Takehiro, et al.
Publicado: (2018)

Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry
por: Luk, Andrea O.Y., et al.
Publicado: (2008)

Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes
por: Merino, Jordi, et al.
Publicado: (2017)

Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
por: Devers, Marion C, et al.
Publicado: (2016)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
por: Belalcazar, L. Maria, et al.
Publicado: (2015)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Physical Activity and the Metabolic Syndrome in Elderly German Men and Women: Results from the population-based KORA Survey
por: Hahn, Valerie, et al.
Publicado: (2009)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
por: Ishimwe, M C Sage, et al.
Publicado: (2021)

Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S.
por: Hoang, Khiet C., et al.
Publicado: (2008)

Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes
por: Freedman, Barry I., et al.
Publicado: (2015)

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
por: Saremi, Aramesh, et al.
Publicado: (2017)

Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis
por: Jansson, Anna K, et al.
Publicado: (2022)

Effect of vitamin D(3) supplementation on glycated hemoglobin (HbA1c), fructosamine, serum lipids, and body mass index: a randomized, double-blinded, placebo-controlled trial among healthy immigrants living in Norway
por: Madar, Ahmed A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u0i2aqa60em47b4b1akpjsks81